09/04/2026
Today, we were proudly joined by members of the EB and rare disease communities at the New York Stock Exchange to ring the Opening Bell® for Rare Ventures. About one year ago, EBRP stood on that same stage. Today, we returned with more momentum and a bigger team to accelerate our work in EB while pioneering a path for rare disease at large.
Headquartered in Pittsburgh and built for the world, Rare Ventures is a first-of-its-kind venture philanthropy platform uniting EBRP with world-leading rare disease experts from Stanford Medicine, Pitt Health Sciences, UPMC Children's Hospital of Pittsburgh, Pitt Ophthalmology/UPMCVisionInstitute, Carnegie Mellon University, and ElevateBio. Together, with these partners, we will combine artificial intelligence, clinical research, therapeutic development, manufacturing and commercialization into a single engine built to accelerate treatments and cures for rare diseases, with EB at the center.
A huge thank you to the Richard King Mellon Foundation for making this vision possible, the New York Stock Exchange for hosting us, and everyone who made this moment a reality. Ringing the bell isn't just symbolic, it's an invitation for the world to stand with us, help us drive research forward, and together we can change the future of EB. 🦋💙
đź“·: New York Stock Exchange